Analytik Jena AG Completes Merger of CyBio AG
News Jul 10, 2014
The merger of CyBio AG into Analytik Jena AG became effective upon entry into the commercial register of Analytik Jena AG (commercial register of the Registry Court of Jena, HRB 200027). As a result, CyBio AG is dissolved as an independent company.
In the future, the Life Science business unit of Analytik Jena AG will continue CyBio Group's business in the areas of liquid handling and laboratory automation. The products will continue to be marketed under the independent CyBio brands.
In the coming years, Analytik Jena also anticipates expanding the liquid-handling area under the well-established product brand. All employees of the previous CyBio AG will be taken on by Analytik Jena with the merger.
"With the successful merger we have finally completed the multi-year integration process of CyBio AG into the Analytik Jena Group. As a result, we are combining the technological expertise and employee resources of both companies and are also in a position to configure our internal organizational structures much more effectively," said Klaus Berka, Chief Executive Officer of Analytik Jena AG.
Analytik Jena AG acquired all still outstanding shares of CyBio AG in connection with the merger. The overwhelming majority of shareholders of CyBio AG drafted a corresponding resolution to transfer the shares of the minority shareholders to Analytik Jena AG as the majority shareholder in return for payment of compensation in cash at the company's General Meeting on May 22, 2014.
Tweak to Technique Could Bolster Disease DetectionNews
A team of Stanford researchers has developed a technique that they hope could more precisely detect diseases or disorders such as cancer or a heart attack.READ MORE
Compact Chemical Sensor Can Detect Substances from Over 100 Feet AwayNews
A chemical sensor prototype developed at the University of Michigan will be able to detect "single-fingerprint quantities" of substances from a distance of more than 100 feet away, and its developers are working to shrink it to the size of a shoe box. The development offers great potential for medical and law enforcement purposes.READ MORE
Multidisciplinary Study Suggests New Strategy for Drug DiscoveryNews
A joint industry/academia study of a cancer target protein reveals unusual relation between binding site flexibility and drug-target lifetime. The results, , suggest a new strategy for drug discovery.READ MORE